Clinnovate Health UK Ltd will become the first life sciences company from Singapore to invest in Scotland, when it launches its Genesis Imaging Services (GIS) laboratory in Glasgow tomorrow (Wednesday 29th March).
Clinnovate Health offers histology and genomics services for the clinical research market in areas of fibrosis and cancer. The Singapore company will test and develop its kidney imaging system for transplant histological assessment at its laboratory in University of Glasgow’s new Imaging Centre of Excellence opened at Glasgow’s Queen Elizabeth University Hospital.
The launch of the Clinnovate Health laboratory yesterday also marked the first ever investment by a Singaporean firm in the Scottish life sciences sector. Clinnovate provides services for the clinical research market in areas of fibrosis and cancer.
Inward investment to Scotland secured 7839 jobs in 2016/17 – an increase of 10% on the previous year
Next this month we look at another of this year’s SMART award winners. Having received £93k to support a feasibility study, Singapore and Scotland based Clinnovate Health is expanding its laboratory work into new fields of medical research.
The Secretary of State for Scotland David Mundell will be in Singapore to highlight these collaborations and identify new areas for Singapore and Scotland to work together in the future. He was joined by a numebr of speakers from Scottish companies and Universities with a presence in Singapore.